116 related articles for article (PubMed ID: 15694185)
1. Monoclonal antibodies in the treatment of indolent lymphomas.
Coiffier B
Best Pract Res Clin Haematol; 2005 Mar; 18(1):69-80. PubMed ID: 15694185
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies combined to chemotherapy for the treatment of patients with lymphoma.
Coiffier B
Blood Rev; 2003 Mar; 17(1):25-31. PubMed ID: 12490208
[TBL] [Abstract][Full Text] [Related]
3. New treatment strategies in lymphomas: aggressive lymphomas.
Coiffier B
Ann Hematol; 2004; 83 Suppl 1():S73-4. PubMed ID: 15124681
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibody therapy for malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
6. Combination of chemotherapy and monoclonal antibodies for the treatment of lymphoma.
Thieblemont C; Coiffier B
Int J Hematol; 2002 Dec; 76(5):394-400. PubMed ID: 12512833
[TBL] [Abstract][Full Text] [Related]
7. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
9. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Aydin S; Dührsen U; Nückel H
Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
[TBL] [Abstract][Full Text] [Related]
10. Antibody therapy for non-Hodgkin's lymphoma.
Ansell SM
Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
[TBL] [Abstract][Full Text] [Related]
11. [Is lymphoma curable with antibody therapy?].
Leppä S; Nyman H; Karjalainen-Lindsberg ML
Duodecim; 2009; 125(3):267-73. PubMed ID: 19341039
[TBL] [Abstract][Full Text] [Related]
12. Progress in immunotherapy rituximab.
El-Habbash MM; Alwindi AM
Saudi Med J; 2007 Nov; 28(11):1635-44. PubMed ID: 17965780
[TBL] [Abstract][Full Text] [Related]
13. [Rituximab in the treatment of B-cell non-Hodgkin lymphoma].
Mitrović Z; Aurer I
Lijec Vjesn; 2006; 128(1-2):36-42. PubMed ID: 16640226
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for the treatment of diffuse large B-cell lymphomas.
Held G; Pöschel V; Pfreundschuh M
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1175-86. PubMed ID: 16925484
[TBL] [Abstract][Full Text] [Related]
15. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
Pagel JM; Laugen C; Bonham L; Hackman RC; Hockenbery DM; Bhatt R; Hollenback D; Carew H; Singer JW; Press OW
Clin Cancer Res; 2005 Jul; 11(13):4857-66. PubMed ID: 16000584
[TBL] [Abstract][Full Text] [Related]
17. Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.
Martin P; Furman RR; Ruan J; Elstrom R; Barrientos J; Niesvizky R; Coleman M; Leonard JP
Semin Hematol; 2008 Apr; 45(2):126-32. PubMed ID: 18381108
[TBL] [Abstract][Full Text] [Related]
18. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B
Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888
[TBL] [Abstract][Full Text] [Related]
19. A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma.
Swaneveld FH; van Vugt RM; de Boer JP; Dijkmans BA; Lems WF
Clin Rheumatol; 2008 Feb; 27(2):249-51. PubMed ID: 17660934
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic characteristics and clinical activity of human rituximab anti-CD20 monoclonal antibody].
Varaldo R; Gobbi M
Ann Ital Med Int; 2003; 18(3):182-7. PubMed ID: 14621431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
